Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...

A new targeted cancer drug, DB-1310, is showing early signs of effectiveness in patients with advanced solid tumors that have ...

Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head ...

A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.

Ivonescimab helped cut the risk of lung tumor progression in half in a multi-country Phase 3 trial. But it hasn’t yet clearly ...

England has rolled out a new liquid biopsy test intended to fast-track lung cancer patients to receive targeted therapy.

Merck (MRK) stock falls as the company withdraws U.S. marketing application for lung cancer therapy HER3-DXd developed with ...

AstraZeneca India Pharma receives government approval for import and distribution of lung cancer medication Osimertinib ...

People with lung cancer will be offered a new blood test designed to speed up access to targeted treatments and avoid ...

A grandad with advanced lung cancer, which often leaves patients dead within four months has become free of the disease after ...